Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies.
Francisco J. Esteva
, Carol D. Cheli
, Herbert Fritsche
, Monica Fornier
, Dennis Slamon
, Robert P. Thiel
, Diana Luftner
, Farooq Ghani
Research output: Contribution to journal › Article › peer-review
141Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies.'. Together they form a unique fingerprint.